Viquglip-M-Forte
Description_Effects
Viquglip-M-Forte is a combination of two antidiabetic medicines: Vildagliptin (50mg) and Metformin (1000mg). It is prescribed to help manage type 2 diabetes mellitus in adults when diet, exercise, and single-drug therapy do not provide adequate glycemic control. Metformin belongs to the biguanide class and works by reducing glucose production in the liver, delaying glucose absorption in the intestines, and improving the body's insulin sensitivity. Vildagliptin is a DPP-4 inhibitor that helps regulate blood sugar levels by increasing the release of insulin and decreasing the production of glucagon only when needed. Together, they offer complementary mechanisms to effectively control blood sugar throughout the day, especially after meals. Maintaining stable blood glucose levels reduces the risk of long-term complications such as kidney failure, nerve damage, retinopathy (eye issues), heart disease, and limb amputation. This medicine is most effective when combined with a healthy lifestyle that includes a balanced diet, regular physical activity, and weight management. It should be taken exactly as prescribed by your doctor and not discontinued without medical advice. Viquglip-M-Forte plays a crucial role in supporting long-term health and helping people with diabetes live an active, balanced life.
